Physician profile
Haritha Ramasastry
NPI 1407900616
$7,965.74
in general payments reported to CMS, 2019-2025
10 companies · $393 in 2025
The $393 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $178 · 2021: $1,103 · 2022: $185 · 2023: $213 · 2024: $5,408 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,945 · Food and Beverage: $931 · Travel and Lodging: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,945.00 |
| Food and Beverage | $931.37 |
| Travel and Lodging | $137.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $5,352.45 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,419.45 | 2019-2025 | Xifaxan |
| Ardelyx, INC. | $353.74 | 2023-2025 | Ibsrela |
| Braintree Laboratories, INC. | $258.95 | 2019-2024 | Sutab, Suflave |
| Allergan, INC. | $258.84 | 2019 | |
| Abbvie INC. | $156.88 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $47.86 | 2019-2021 | |
| Redhill Biopharma INC. | $46.16 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $42.74 | 2019-2024 | Linzess |
| Evoke Pharma, INC. | $28.67 | 2023 | Gimoti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haritha Ramasastry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.